Alzheimer's Disease Trial, Recruiting NCT05561205 Sponsor: Sunnybrook Health Sciences Centre Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05561205
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with mild or major neurocognitive disorder, or mild behavioural impairment.
  • People who have been experiencing apathy (a persistent lack of motivation or interest) for at least 4 weeks.
  • People whose medications that may affect thinking or behaviour have been at a stable dose for more than 4 weeks.
  • People who have a care partner (such as a family member or carer) who spends at least 10 hours per week with them.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently experiencing a major depressive episode.
  • People who are currently experiencing agitation, delusions, or hallucinations.
  • People who have a medical reason that prevents them from safely receiving rTMS (repetitive transcranial magnetic stimulation, a type of brain stimulation therapy).
  • People who are currently taking any amphetamine-based medication.
  • People who have certain abnormalities affecting the brain or nervous system, Tourette's syndrome, or motor tics (involuntary repeated movements).
  • People who are currently taking part in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 February 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Neuropsychiatric Inventory-apathy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov